Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Bacterial Infections and Mycoses

Free Subscription Articles published in Chest Retrieve available abstracts of 37 articles: HTML format

Single Articles

March 2026
1. KATAGIRA W, Orme MW, Kasiita R, Matheson JA, et al
   Clinical and cost-effectiveness of pulmonary rehabilitation for people with post-tuberculosis lung disease in Uganda: a randomised controlled trial.
   Chest. 2026 Mar 6:S0012-3692(26)00273-4. doi: 10.1016/j.chest.2025.
   PubMed     Abstract available
   
   
   
2. VYAS YK
   17-Year-Old Male Patient With Pulmonary TB Presenting With Tingling and Numbness in the Left Upper Limb.
   Chest. 2026;169:e103-e107.
   PubMed     Abstract available
   
   
   
3. PULSIPHER AM, Vikram HR, Gotway MB, Cartin-Ceba R, et al
   Adjunctive Corticosteroid Use and Clinical Outcomes in Non-HIV Pneumocystis jirovecii Pneumonia.
   Chest. 2026;169:616-625.
   PubMed     Abstract available
   
   
   February 2026
4. JO KW, Lee JB, Lee J, Lee HN, et al
   Impact of Treatment Outcome on Mortality in Mycobacterium abscessus Complex Pulmonary Disease.
   Chest. 2026;169:349-359.
   PubMed     Abstract available
   
   
   January 2026
5. METERSKY ML, Hunt CR, Addrizzo-Harris DJ, Aksamit TR, et al
   The Bronchiectasis and Non-Tuberculous Mycobacterial Care Center Network: Improving Access and Quality of Care.
   Chest. 2026;169:34-36.
   PubMed    
   
   
   December 2025
6. TIEW PY, Narayana JK, Jaggi TK, Koh MS, et al
   Aspergillus fumigatus sensitization is associated with high-risk bronchiectasis.
   Chest. 2025 Dec 10:S0012-3692(25)05826-X. doi: 10.1016/j.chest.2025.
   PubMed     Abstract available
   
   
   September 2025
7. SINHA P, Karoly M, Padmapriyadarsini C, Paradkar M, et al
   Contribution of Key Comorbidities to Unfavorable Treatment Outcomes among Adults with Drug-sensitive Pulmonary Tuberculosis in India: a Prospective Cohort Analysis.
   Chest. 2025 Sep 10:S0012-3692(25)05171-2. doi: 10.1016/j.chest.2025.
   PubMed     Abstract available
   
   
   July 2025
8. CHEN C, Xue H, Horsburgh CR, Amour M, et al
   Trajectories of Interferon-Gamma Release Assay Results Over 2 Years in Independent Cohorts From China, South Africa, Tanzania, and the United States.
   Chest. 2025;168:33-42.
   PubMed     Abstract available
   
   
   May 2025
9. JIANG J, Rao Y, Liu C, Chang SJ, et al
   A 7-Year-Old Girl With Multiple Pulmonary Nodules.
   Chest. 2025;167:e161-e165.
   PubMed     Abstract available
   
   
   
10. DONOVAN FM, Thompson GR 3rd, Blair JE, Johnson RH, et al
    Managing Cavitary Coccidioidomycosis Expert Opinions for Improving Patient Outcomes.
    Chest. 2025;167:1311-1320.
    PubMed     Abstract available
    
    
    April 2025
11. AGARWAL R, Muthu V, Sehgal IS
    Evaluation for Allergic Bronchopulmonary Aspergillosis in Patients With Bronchiectasis.
    Chest. 2025;167:e143.
    PubMed    
    
    
    
12. CARTER C, Shah A
    The Fungal Frontier: Understanding the Impact of Aspergillus in Bronchiectasis.
    Chest. 2025;167:914-916.
    PubMed    
    
    
    March 2025
13. LEE J, Park SJ, Kim S, Lee HN, et al
    Isolation of Genetically Distinct Strains Within the Same Species During Treatment of Mycobacterium Avium Complex Pulmonary Disease.
    Chest. 2025;167:675-685.
    PubMed     Abstract available
    
    
    February 2025
14. JAIN R, Peng G, Lee M, Keller A, et al
    Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Maternal Outcomes During and After Pregnancy.
    Chest. 2025;167:348-361.
    PubMed     Abstract available
    
    
    
15. WAHAB A, Sanborn D, Vergidis P, Razonable R, et al
    Diagnosis and Prevention of Invasive Fungal Infections in the Immunocompromised Host.
    Chest. 2025;167:374-386.
    PubMed     Abstract available
    
    
    January 2025
16. KIM H, Jo E, Kim J, Lee N, et al
    Diagnostic Performance of the Modified Lung-RADS in a Tuberculosis-endemic Country: The Korean National Lung Cancer Screening Program.
    Chest. 2025 Jan 28:S0012-3692(25)00133-3. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
17. JIANG Y, Huang X, Zhou H, Wang M, et al
    Clinical Characteristics and Prognosis of Patients With Severe Pneumonia With Pneumocystis jirovecii Colonization: A Multicenter, Retrospective Study.
    Chest. 2025;167:54-66.
    PubMed     Abstract available
    
    
    December 2024
18. EVEN-DAR R, Raz I, Brodsky M, Stein N, et al
    Non- Tuberculous mycobacterial infection and pulmonary disease In Northern Israel: a focus on M. simiae.
    Chest. 2024 Dec 2:S0012-3692(24)05600-9. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    November 2024
19. HOLTROP M, Cosmich S, Lee M, Keller A, et al
    Sex Differences After Treatment With Ivacaftor in People With Cystic Fibrosis.
    Chest. 2024;166:951-962.
    PubMed     Abstract available
    
    
    October 2024
20. CHOI H, Hughes C, Eke Z, Shuttleworth M, et al
    Clinical Efficacy of Serum Anti-glycopeptidolipid-core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort Study.
    Chest. 2024 Oct 25:S0012-3692(24)05418-7. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
21. POLLOCK J, Goeminne PC, Aliberti S, Polverino E, et al
    Aspergillus serology and clinical outcomes in patients with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
    Chest. 2024 Oct 24:S0012-3692(24)05400-X. doi: 10.1016/j.chest.2024.06.3843.
    PubMed     Abstract available
    
    
    
22. GABORIT B, Lecuyer R, Issa N, Camou F, et al
    Should We Reconsider Pneumocystis Pneumonia Presentation and Treatment According to Its Underlying Disease?: An Unsupervised Cluster Analysis of a Retrospective Multicenter Study.
    Chest. 2024;166:708-711.
    PubMed    
    
    
    
23. JOEAN O, von Eynern LP, Welte T, Einecke G, et al
    Clinical Features, Diagnostics, Etiology, and Outcomes of Hospitalized Solid Organ Recipients With Community-Acquired Pneumonia: A Retrospective Cohort Analysis.
    Chest. 2024;166:697-707.
    PubMed     Abstract available
    
    
    September 2024
24. LEE JK, Kim S, Chong YP, Lee HJ, et al
    The Association Between Sputum Culture Conversion and Mortality in Cavitary Mycobacterium avium Complex Pulmonary Disease.
    Chest. 2024;166:442-451.
    PubMed     Abstract available
    
    
    
25. HYUNG K, Kim SA, Kim JY, Kwak N, et al
    Rates and Risk Factors of Progression in Patients With Nontuberculous Mycobacterial Pulmonary Disease: Secondary Analysis of a Prospective Cohort Study.
    Chest. 2024;166:452-460.
    PubMed     Abstract available
    
    
    August 2024
26. PEDERSEN AA, Lokke A, Floe A, Ibsen R, et al
    Nationwide Increasing Incidence of Nontuberculous Mycobacterial Diseases Among Adults in Denmark: Eighteen Years of Follow-Up.
    Chest. 2024;166:271-280.
    PubMed     Abstract available
    
    
    July 2024
27. BAI AD, Srivastava S, Digby GC, Girard V, et al
    Anaerobic Antibiotic Coverage in Aspiration Pneumonia and the Associated Benefits and Harms: A Retrospective Cohort Study.
    Chest. 2024;166:39-48.
    PubMed     Abstract available
    
    
    
28. FELZER JR, Montgomery AJ, LeMahieu AM, Finney Rutten LJ, et al
    Disparities in Influenza, Pneumococcal, COVID-19 Vaccine Coverage in High-Risk Adults Aged 19 to 64 Years in Southeastern Minnesota, 2010-2021.
    Chest. 2024;166:49-60.
    PubMed     Abstract available
    
    
    June 2024
29. SCHERGER SJ, Kalil AC
    Changes in the Mortality Rate and Epidemiology of Pneumocystis Pneumonia Require Novel Approaches to Clinical Care.
    Chest. 2024;165:1273-1275.
    PubMed    
    
    
    
30. LECUYER R, Issa N, Camou F, Lavergne RA, et al
    Characteristics and Prognosis Factors of Pneumocystis jirovecii Pneumonia According to Underlying Disease: A Retrospective Multicenter Study.
    Chest. 2024;165:1319-1329.
    PubMed     Abstract available
    
    
    May 2024
31. ZWEIJPFENNING SMH, Aarnoutse R, Boeree MJ, Magis-Escurra C, et al
    Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized Trial.
    Chest. 2024;165:1082-1092.
    PubMed     Abstract available
    
    
    March 2024
32. WALKER MK, Kadri SS
    Generalizing the Use of a Procalcitonin-Guided Antibiotic Algorithm to a New Era of SARS-CoV-2 Infection.
    Chest. 2024;165:e85-e86.
    PubMed    
    
    
    
33. THIZY G, Flahault A, Scemla A, Roux O, et al
    Legionnaires Disease in Solid Organ Transplant Recipients: A Decade-Long Nationwide Study in France.
    Chest. 2024;165:507-520.
    PubMed     Abstract available
    
    
    
34. YAN M, Fraser B, McArthur E, Mehrabi M, et al
    External Validation of the BACES Score in Canadian Patients With Nontuberculous Mycobacterial Pulmonary Disease.
    Chest. 2024;165:521-528.
    PubMed     Abstract available
    
    
    
35. AZAR MM
    A Diagnostic Approach to Fungal Pneumonia: An Infectious Diseases Perspective.
    Chest. 2024;165:559-572.
    PubMed     Abstract available
    
    
    December 2023
36. NAEGER S, Pool V, Macina D
    Increased burden of pertussis among adolescents and adults with asthma or COPD in the US, 2007-2019.
    Chest. 2023 Dec 19:S0012-3692(23)05934-2. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available
    
    
    
37. KU JH, Henkle E, Carlson KF, Marino M, et al
    Tolerability outcomes of ATS/IDSA guideline-recommended multi-drug antibiotic treatment for Mycobacterium avium complex pulmonary disease in U.S. Medicare beneficiaries with bronchiectasis.
    Chest. 2023 Dec 10:S0012-3692(23)05846-4. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum